Aspirin Use and Liver-Related Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis

<b>Background:</b> Given aspirin’s biologic plausibility for antifibrotic and antineoplastic effects, we conducted a systematic review and meta-analysis to examine the association between aspirin use and major liver-related outcomes in metabolic dysfunction-associated steatotic liver disease (MASLD)...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Fares Jamal, Abdullah Hamad, Amani Elshaer, Pierce L. Claassen, Taylor Viggiano, Michele Barnhill, David M. H. Chascsa, Hugo E. Vargas, Bashar A. Aqel, Blanca C. Lizaola-Mayo
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2026-05-01
Serie:	Biomedicines
Soggetti:	MASLD MASH aspirin acetylsalicylic acid NAFLD NASH
Accesso online:	https://www.mdpi.com/2227-9059/14/6/1249
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!